Division of Internal Medicine 2023 Research Retreat (DoIM)

---

LIVE

Thursday, June 15, 2023, 2:00 PM - Friday, June 16, 2023, 1:00 PM, MD Anderson - Duncan Building, Houston, TX

The emphasis of this annual research retreat is to: encourage collaboration, highlight research accomplishments, and provide opportunities for innovation and discovery.

The in-person Poster Session is Thursday, June 15. Posters are encouraged for all abstracts submitted - both Cyrus Award-eligible and non-eligible research. All posters submitted are accepted for display.  Poster Award Finalists are pre-selected from the top five scoring posters in the categories of Basic Science, Clinical Research, and Quality Improvement.  A roving panel of judges will evaluate finalist’s poster presentations and winners will be announced on Friday.  Finalists must be present at the Poster Session to be considered.  

The hybrid Research Retreat is to be held Friday, June 16. The Keynote Speaker will be Lisa M. Coussens, MD, (h.c.), PhD, FAACR, followed by the Cyrus Scholar Awards in the categories of Basic Science and Clinical Research. A panel of Distinguished Judges from MD Anderson will score the Cyrus Scholar presentations and select two winners.

1. encourage collaboration between colleagues;
2. highlight research accomplishments; and
3. provide innovation and discovery opportunities.

The Research Retreat opens at 2:00 PM on Thursday, June 15, 2023 with the Poster Session. The Research Retreat will continue with the Keynote Address at 8:00 AM on Friday, June 16, and  will adjourn at Noon.

LOCATION NOTICE:

• Poster Session will be held in CPB / Duncan Building - Thursday, June 15
  
  
• Research Retreat will be held in Hickey Auditorium - Friday, June 16

FREE REGISTRATION: Online registration is required. 

• In-Person Attendance (includes lunch) - MDACC Employees Only 
• Virtual Attendance - live internet streaming (details and login information will be provided via emailed the week of the retreat) - MDACC Employees Only

Call for Abstracts
Division of Internal Medicine faculty, fellows and staff may submit abstracts for presentation involving original research.  Abstracts not presented at the 2022 DoIM Research Retreat but previously accepted, presented or published will be accepted.

All abstracts submitted by instructors, assistant professors and associate professors automatically qualify for the Cyrus Scholar Awards competition.  Winners from 2019 - 2022 are not eligible to compete for the Cyrus Scholar Awards.

Abstract Submissions Deadline - April 03, 2023

Abstract Instructions and Submission Form- click here

Cancellation Policy
The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, email or at the phone or fax numbers given on the registration form.

CPE reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available.

Additional Information
Please contact Eric Gagneaux, Manager, CE Activity Management, Continuing Professional Education, 713-745-0080; or  Jessica Hunter, Administrative Coordinator, Division Research Planning and Development, 713-792-4518

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.